{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:17:17Z","timestamp":1788513437849,"version":"build-2803163510"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12264-026-01613-6","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:37:25Z","timestamp":1774679845000},"page":"2127-2150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Decode the Ubiquitinome in Parkinson\u2019s Disease: From Pathological Aggregates to Targeted DUB Therapeutics"],"prefix":"10.1007","volume":"42","author":[{"given":"Xi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinshuai","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-1956","authenticated-orcid":false,"given":"Huamin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-7901","authenticated-orcid":false,"given":"Junxia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-7215","authenticated-orcid":false,"given":"Yingjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"1613_CR1","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1038\/s41467-024-50718-x","volume":"15","author":"A Doostparast Torshizi","year":"2024","unstructured":"Doostparast Torshizi A, Truong DT, Hou L, Smets B, Whelan CD, Li S. Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson\u2019s disease. Nat Commun. 2024, 15: 6430.","journal-title":"Nat Commun."},{"key":"1613_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41467-025-56737-6","volume":"16","author":"J Gao","year":"2025","unstructured":"Gao J, Liu Y, Si C, Guo R, Hou S, Liu X. Aspirin inhibits proteasomal degradation and promotes \u03b1-synuclein aggregate clearance through K63 ubiquitination. Nat Commun 2025, 16: 1438.","journal-title":"Nat Commun"},{"key":"1613_CR3","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s11427-020-1756-9","volume":"63","author":"R Wang","year":"2020","unstructured":"Wang R, Sun H, Ren H, Wang G. \u03b1-Synuclein aggregation and transmission in Parkinson\u2019s disease: A link to mitochondria and lysosome. Sci China Life Sci 2020, 63: 1850\u20131859.","journal-title":"Sci China Life Sci"},{"key":"1613_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102319","volume":"98","author":"B Li","year":"2024","unstructured":"Li B, Xiao X, Bi M, Jiao Q, Chen X, Yan C, et al. Modulating \u03b1-synuclein propagation and decomposition: Implications in Parkinson\u2019s disease therapy. Ageing Res Rev 2024, 98: 102319.","journal-title":"Ageing Res Rev"},{"key":"1613_CR5","doi-asserted-by":"crossref","unstructured":"Qin F, Cao R, Cui W, Bai X, Yuan J, Zhang Y, et al. Listerin promotes \u03b1-synuclein degradation to alleviate Parkinson\u2019s disease through the ESCRT pathway. Sci Adv 2025, 11: eadp3672.","DOI":"10.1126\/sciadv.adp3672"},{"key":"1613_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108857","volume":"34","author":"ND Roverato","year":"2021","unstructured":"Roverato ND, Sailer C, Catone N, Aichem A, Stengel F, Groettrup M. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy. Cell Rep 2021, 34: 108857.","journal-title":"Cell Rep"},{"key":"1613_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-021-00243-4","volume":"10","author":"KY Ma","year":"2021","unstructured":"Ma KY, Fokkens MR, Reggiori F, Mari M, Verbeek DS. Parkinson\u2019s disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1\/Parkin-mediated mitophagy. Transl Neurodegener 2021, 10: 19.","journal-title":"Transl Neurodegener"},{"key":"1613_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41380-021-01233-8","volume":"27","author":"B Liu","year":"2022","unstructured":"Liu B, Ruan J, Chen M, Li Z, Manjengwa G, Schl\u00fcter D, et al. Deubiquitinating enzymes (DUBs): Decipher underlying basis of neurodegenerative diseases. Mol Psychiatry 2022, 27: 259\u2013268.","journal-title":"Mol Psychiatry"},{"key":"1613_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101367","volume":"69","author":"HA Do","year":"2021","unstructured":"Do HA, Baek KH. Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases. Ageing Res Rev 2021, 69: 101367.","journal-title":"Ageing Res Rev"},{"key":"1613_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41419-022-04704-0","volume":"13","author":"F Jia","year":"2022","unstructured":"Jia F, Li H, Jiao Q, Li C, Fu L, Cui C, et al. Deubiquitylase OTUD3 prevents Parkinson\u2019s disease through stabilizing iron regulatory protein 2. Cell Death Dis 2022, 13: 418.","journal-title":"Cell Death Dis"},{"key":"1613_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbrc.2019.11.141","volume":"522","author":"X Cheng","year":"2020","unstructured":"Cheng X, Xu S, Zhang C, Qin K, Yan J, Shao X. The BRCC3 regulated by Cdk5 promotes the activation of neuronal NLRP3 inflammasome in Parkinson\u2019s disease models. Biochem Biophys Res Commun 2020, 522: 647\u2013654.","journal-title":"Biochem Biophys Res Commun"},{"key":"1613_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00018-024-05246-8","volume":"81","author":"L Ding","year":"2024","unstructured":"Ding L, Lu L, Zheng S, Zhang Z, Huang X, Ma R, et al. Usp14 deficiency removes \u03b1-synuclein by regulating S100A8\/A9 in Parkinson\u2019s disease. Cell Mol Life Sci 2024, 81: 232.","journal-title":"Cell Mol Life Sci"},{"key":"1613_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116753","volume":"175","author":"L Lu","year":"2024","unstructured":"Lu L, Jifu C, Xia J, Wang J. E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases. Biomed Pharmacother 2024, 175: 116753.","journal-title":"Biomed Pharmacother"},{"key":"1613_CR14","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam TI, Wang H, Neifert S, Chou SC, Kumar M, et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron 2022, 110: 2422-2437.e9.","journal-title":"Neuron"},{"key":"1613_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102575","volume":"102","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Anwar S, Venkatesan K, Shahwan M, Hassan MI, Islam A, et al. Iron homeostasis and neurodegeneration in the ageing brain: Insight into ferroptosis pathways. Ageing Res Rev 2024, 102: 102575.","journal-title":"Ageing Res Rev"},{"key":"1613_CR16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/hmg\/ddm363","volume":"17","author":"JT Lee","year":"2008","unstructured":"Lee JT, Wheeler TC, Li L, Chin LS. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death. Hum Mol Genet 2008, 17: 906\u2013917.","journal-title":"Hum Mol Genet"},{"key":"1613_CR17","doi-asserted-by":"crossref","unstructured":"Zenko D, Marsh J, Castle AR, Lewin R, Fischer R, Tofaris GK. Monitoring \u03b1-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation. Sci Adv 2023, 9: eadd8910.","DOI":"10.1126\/sciadv.add8910"},{"key":"1613_CR18","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/ijms23073705","volume":"23","author":"O Buneeva","year":"2022","unstructured":"Buneeva O, Medvedev A. Atypical ubiquitination and Parkinson\u2019s disease. Int J Mol Sci 2022, 23: 3705.","journal-title":"Int J Mol Sci"},{"key":"1613_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: From mechanisms to novel therapeutic approaches. Mol Cancer 2024, 23: 148.","journal-title":"Mol Cancer"},{"key":"1613_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41531-023-00601-1","volume":"9","author":"L Schorova","year":"2023","unstructured":"Schorova L, Bedard N, Khayachi A, Ho HH, Bolivar-Pedroso J, Huynh J, et al. USP19 deubiquitinase inactivation regulates \u03b1-synuclein ubiquitination and inhibits accumulation of Lewy body-like aggregates in mice. NPJ Parkinsons Dis 2023, 9: 157.","journal-title":"NPJ Parkinsons Dis"},{"key":"1613_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.it.2021.12.005","volume":"43","author":"C Madiraju","year":"2022","unstructured":"Madiraju C, Novack JP, Reed JC, Matsuzawa SI. K63 ubiquitination in immune signaling. Trends Immunol 2022, 43: 148\u2013162.","journal-title":"Trends Immunol"},{"key":"1613_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13020-025-01085-2","volume":"20","author":"YL Wang","year":"2022","unstructured":"Wang YL, You J, Cao JJ, Li W, Jing LY, Mei QB, et al. Screening of the ubiquitin-proteasome system activators for anti-Alzheimer\u2019s disease by the high-content fluorescence imaging system. Chin J Nat Med 2022, 20: 33\u201342.","journal-title":"Chin J Nat Med"},{"key":"1613_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molcel.2016.09.014","volume":"64","author":"F Ohtake","year":"2016","unstructured":"Ohtake F, Saeki Y, Ishido S, Kanno J, Tanaka K. The K48\u2013K63 branched ubiquitin chain regulates NF-\u03baB signaling. Mol Cell 2016, 64: 251\u2013266.","journal-title":"Mol Cell"},{"key":"1613_CR24","doi-asserted-by":"publisher","first-page":"11792","DOI":"10.1038\/ncomms11792","volume":"7","author":"FC Nucifora","year":"2016","unstructured":"Nucifora FC, Nucifora LG, Ng CH, Arbez N, Guo Y, Roby E, et al. Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1. Nat Commun 2016, 7: 11792.","journal-title":"Nat Commun"},{"key":"1613_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.molcel.2010.07.001","volume":"39","author":"ML Matsumoto","year":"2010","unstructured":"Matsumoto ML, Wickliffe KE, Dong KC, Yu C, Bosanac I, Bustos D, et al. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 2010, 39: 477\u2013484.","journal-title":"Mol Cell"},{"key":"1613_CR26","doi-asserted-by":"crossref","unstructured":"Spit M, Rieser E, Walczak H. Linear ubiquitination at a glance. J Cell Sci 2019, 132: jcs208512.","DOI":"10.1242\/jcs.208512"},{"key":"1613_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41418-020-00676-w","volume":"28","author":"AS Jahan","year":"2021","unstructured":"Jahan AS, Elb\u00e6k CR, Damgaard RB. Met1-linked ubiquitin signalling in health and disease: Inflammation, immunity, cancer, and beyond. Cell Death Differ 2021, 28: 473\u2013492.","journal-title":"Cell Death Differ"},{"key":"1613_CR28","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201489729","volume":"33","author":"TM Durcan","year":"2014","unstructured":"Durcan TM, Tang MY, P\u00e9russe JR, Dashti EA, Aguileta MA, McLelland GL, et al. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J 2014, 33: 2473\u20132491.","journal-title":"EMBO J"},{"key":"1613_CR29","doi-asserted-by":"publisher","first-page":"10378","DOI":"10.1073\/pnas.1912984117","volume":"117","author":"Q Lin","year":"2020","unstructured":"Lin Q, Yu B, Wang X, Zhu S, Zhao G, Jia M, et al. K6-linked SUMOylation of BAF regulates nuclear integrity and DNA replication in mammalian cells. Proc Natl Acad Sci U S A 2020, 117: 10378\u201310387.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.molcel.2014.03.035","volume":"54","author":"WC Yuan","year":"2014","unstructured":"Yuan WC, Lee YR, Lin SY, Chang LY, Tan YP, Hung CC, et al. K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin E3 ligase regulates protein trafficking. Mol Cell 2014, 54: 586\u2013600.","journal-title":"Mol Cell"},{"key":"1613_CR31","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41589-021-00823-5","volume":"17","author":"Y Yu","year":"2021","unstructured":"Yu Y, Zheng Q, Erramilli SK, Pan M, Park S, Xie Y, et al. K29-linked ubiquitin signaling regulates proteotoxic stress response and cell cycle. Nat Chem Biol 2021, 17: 896\u2013905.","journal-title":"Nat Chem Biol"},{"key":"1613_CR32","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.7150\/ijbs.111867","volume":"21","author":"SK Hsu","year":"2025","unstructured":"Hsu SK, Kuo IY, Lin PY, Chou CK, Ko CC, Chang WT, et al. Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention. Int J Biol Sci 2025, 21: 3993\u20134009.","journal-title":"Int J Biol Sci"},{"key":"1613_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70036","volume":"5","author":"Y Xian","year":"2024","unstructured":"Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W, et al. Deubiquitinases as novel therapeutic targets for diseases. MedComm 2024, 5: e70036.","journal-title":"MedComm"},{"key":"1613_CR34","doi-asserted-by":"publisher","first-page":"E4688","DOI":"10.1073\/pnas.1523597113","volume":"113","author":"Z Alexopoulou","year":"2016","unstructured":"Alexopoulou Z, Lang J, Perrett RM, Elschami M, Hurry MED, Kim HT, et al. Deubiquitinase Usp8 regulates \u03b1-synuclein clearance and modifies its toxicity in Lewy body disease. Proc Natl Acad Sci U S A 2016, 113: E4688\u2013E4697.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR35","doi-asserted-by":"crossref","unstructured":"Engelender S. \u03b1-synuclein fate: Proteasome or autophagy Autophagy 2012, 8: 418\u2013420.","DOI":"10.4161\/auto.19085"},{"key":"1613_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5483\/BMBRep.2021.54.12.107","volume":"54","author":"GH Park","year":"2021","unstructured":"Park GH, Park JH, Chung KC. Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson\u2019s disease. BMB Rep 2021, 54: 592\u2013600.","journal-title":"BMB Rep"},{"key":"1613_CR37","doi-asserted-by":"publisher","first-page":"18666","DOI":"10.1073\/pnas.1105725108","volume":"108","author":"R Rott","year":"2011","unstructured":"Rott R, Szargel R, Haskin J, Bandopadhyay R, Lees AJ, Shani V, et al. \u03b1-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A 2011, 108: 18666\u201318671.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR38","doi-asserted-by":"publisher","first-page":"2406700","DOI":"10.1002\/advs.202406700","volume":"12","author":"X Song","year":"2025","unstructured":"Song X, Liu T, Yu L, Ji Q, Guo X, Zong R, et al. OTUD5 protects dopaminergic neurons by promoting the degradation of \u03b1-synuclein in Parkinson\u2019s disease model. Adv Sci 2025, 12: 2406700.","journal-title":"Adv Sci"},{"key":"1613_CR39","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1038\/s41467-023-39652-6","volume":"14","author":"K Irmady","year":"2023","unstructured":"Irmady K, Hale CR, Qadri R, Fak J, Simelane S, Carroll T, et al. Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson\u2019s disease. Nat Commun 2023, 14: 3956.","journal-title":"Nat Commun"},{"key":"1613_CR40","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/hmg\/ddn037","volume":"17","author":"T Kabuta","year":"2008","unstructured":"Kabuta T, Setsuie R, Mitsui T, Kinugawa A, Sakurai M, Aoki S, et al. Aberrant molecular properties shared by familial Parkinson\u2019s disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum Mol Genet 2008, 17: 1482\u20131496.","journal-title":"Hum Mol Genet"},{"key":"1613_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuint.2006.07.015","volume":"50","author":"R Setsuie","year":"2007","unstructured":"Setsuie R, Wang YL, Mochizuki H, Osaka H, Hayakawa H, Ichihara N, et al. Dopaminergic neuronal loss in transgenic mice expressing the Parkinson\u2019s disease-associated UCH-L1 I93M mutant. Neurochem Int 2007, 50: 119\u2013129.","journal-title":"Neurochem Int"},{"key":"1613_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/JPD-191754","volume":"10","author":"L Mursaleen","year":"2020","unstructured":"Mursaleen L, Somavarapu S, Zariwala MG. Deferoxamine and curcumin loaded nanocarriers protect against rotenone-induced neurotoxicity. J Parkinsons Dis 2020, 10: 99\u2013111.","journal-title":"J Parkinsons Dis"},{"key":"1613_CR43","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1073\/pnas.1812413116","volume":"116","author":"AT Reinicke","year":"2019","unstructured":"Reinicke AT, Laban K, Sachs M, Kraus V, Walden M, Damme M, et al. Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks. Proc Natl Acad Sci U S A 2019, 116: 7963\u20137972.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR44","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.RA119.009546","volume":"295","author":"R Kumari","year":"2020","unstructured":"Kumari R, Kumar R, Kumar S, Singh AK, Hanpude P, Jangir D, et al. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson\u2019s disease. J Biol Chem 2020, 295: 3466\u20133484.","journal-title":"J Biol Chem"},{"key":"1613_CR45","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1021\/acschemneuro.1c00855","volume":"13","author":"R Kumari","year":"2022","unstructured":"Kumari R, Kumar R, Dey AK, Saha S, Maiti TK. S-nitrosylation of OTUB1 alters its stability and Ubc13 binding. ACS Chem Neurosci 2022, 13: 1517\u20131525.","journal-title":"ACS Chem Neurosci"},{"key":"1613_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.expneurol.2012.06.032","volume":"238","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Cho DH, Lipton SA. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases. Exp Neurol 2012, 238: 12\u201321.","journal-title":"Exp Neurol"},{"key":"1613_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbrc.2023.01.030","volume":"645","author":"SS Park","year":"2023","unstructured":"Park SS, Do HA, Park HB, Choi HS, Baek KH. Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes \u03b1-synuclein. Biochem Biophys Res Commun 2023, 645: 124\u2013131.","journal-title":"Biochem Biophys Res Commun"},{"key":"1613_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.889166","volume":"10","author":"FA Rossi","year":"2022","unstructured":"Rossi FA, Rossi M. Emerging role of ubiquitin-specific protease 19 in oncogenesis and cancer development. Front Cell Dev Biol 2022, 10: 889166.","journal-title":"Front Cell Dev Biol"},{"key":"1613_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcdb.2018.03.006","volume":"83","author":"Y Ye","year":"2018","unstructured":"Ye Y. Regulation of protein homeostasis by unconventional protein secretion in mammalian cells. Semin Cell Dev Biol 2018, 83: 29\u201335.","journal-title":"Semin Cell Dev Biol"},{"key":"1613_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022225","volume":"6","author":"E Emmanouilidou","year":"2011","unstructured":"Emmanouilidou E, Elenis D, Papasilekas T, Stranjalis G, Gerozissis K, Ioannou PC, et al. Assessment of \u03b1-synuclein secretion in mouse and human brain parenchyma. PLoS One 2011, 6: e22225.","journal-title":"PLoS One"},{"key":"1613_CR51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb3372","volume":"18","author":"JG Lee","year":"2016","unstructured":"Lee JG, Takahama S, Zhang G, Tomarev SI, Ye Y. Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. Nat Cell Biol 2016, 18: 765\u2013776.","journal-title":"Nat Cell Biol"},{"key":"1613_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/cells12040651","volume":"12","author":"PY\u00d8 Nielsen","year":"2023","unstructured":"Nielsen PY\u00d8, Okarmus J, Meyer M. Role of deubiquitinases in Parkinson\u2019s disease-therapeutic perspectives. Cells 2023, 12: 651.","journal-title":"Cells"},{"key":"1613_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brainres.2007.12.014","volume":"1195","author":"F Bruzzone","year":"2008","unstructured":"Bruzzone F, Vallarino M, Berruti G, Angelini C. Expression of the deubiquitinating enzyme mUBPy in the mouse brain. Brain Res 2008, 1195: 56\u201366.","journal-title":"Brain Res"},{"key":"1613_CR54","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1093\/hmg\/ddu244","volume":"23","author":"T Cornelissen","year":"2014","unstructured":"Cornelissen T, Haddad D, Wauters F, Van Humbeeck C, Mandemakers W, Koentjoro B, et al. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum Mol Genet 2014, 23: 5227\u20135242.","journal-title":"Hum Mol Genet"},{"key":"1613_CR55","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fphys.2020.00535","volume":"11","author":"J Chakraborty","year":"2020","unstructured":"Chakraborty J, Ziviani E. Deubiquitinating enzymes in Parkinson\u2019s disease. Front Physiol 2020, 11: 535.","journal-title":"Front Physiol"},{"key":"1613_CR56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/genes1030413","volume":"1","author":"A Borchers","year":"2010","unstructured":"Borchers A, Pieler T. Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs. Genes 2010, 1: 413\u2013426.","journal-title":"Genes"},{"key":"1613_CR57","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature13418","volume":"510","author":"B Bingol","year":"2014","unstructured":"Bingol B, Tea JS, Phu L, Reichelt M, Bakalarski CE, Song Q, et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 2014, 510: 370\u2013375.","journal-title":"Nature"},{"key":"1613_CR58","first-page":"18","volume":"2017","author":"E Bahar","year":"1989","unstructured":"Bahar E, Kim JY, Yoon H. Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS\/NF-\u03baB and HO-1\/Nrf2 pathways. Int J Mol Sci 1989, 2017: 18.","journal-title":"Int J Mol Sci"},{"key":"1613_CR59","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/15548627.2019.1656957","volume":"16","author":"K Niu","year":"2020","unstructured":"Niu K, Fang H, Chen Z, Zhu Y, Tan Q, Wei D, et al. USP33 deubiquitinates PRKN\/parkin and antagonizes its role in mitophagy. Autophagy 2020, 16: 724\u2013734.","journal-title":"Autophagy"},{"key":"1613_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111641","volume":"384","author":"S Geisler","year":"2019","unstructured":"Geisler S, J\u00e4ger L, Golombek S, Nakanishi E, Hans F, Casadei N, et al. Ubiquitin-specific protease USP36 knockdown impairs Parkin-dependent mitophagy via downregulation of Beclin-1-associated autophagy-related ATG14L. Exp Cell Res 2019, 384: 111641.","journal-title":"Exp Cell Res"},{"key":"1613_CR61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbrc.2021.05.051","volume":"563","author":"H Kim","year":"2021","unstructured":"Kim H, Lee JY, Park SJ, Kwag E, Koo O, Shin JH. ZNF746\/PARIS promotes the occurrence of hepatocellular carcinoma. Biochem Biophys Res Commun 2021, 563: 98\u2013104.","journal-title":"Biochem Biophys Res Commun"},{"key":"1613_CR62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.bbr.2018.06.005","volume":"356","author":"L Chen","year":"2019","unstructured":"Chen L, Xue L, Zheng J, Tian X, Zhang Y, Tong Q. PPAR\u00df\/\u03b4 agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 2019, 356: 483\u2013489.","journal-title":"Behav Brain Res"},{"key":"1613_CR63","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1074\/jbc.M111.288449","volume":"287","author":"TM Durcan","year":"2012","unstructured":"Durcan TM, Kontogiannea M, Bedard N, Wing SS, Fon EA. Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme. J Biol Chem 2012, 287: 531\u2013541.","journal-title":"J Biol Chem"},{"key":"1613_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/hmg\/ddq452","volume":"20","author":"TM Durcan","year":"2011","unstructured":"Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, et al. The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet 2011, 20: 141\u2013154.","journal-title":"Hum Mol Genet"},{"key":"1613_CR65","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/auto.7.2.14224","volume":"7","author":"TM Durcan","year":"2011","unstructured":"Durcan TM, Fon EA. Mutant ataxin-3 promotes the autophagic degradation of parkin. Autophagy 2011, 7: 233\u2013234.","journal-title":"Autophagy"},{"key":"1613_CR66","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/hmg\/ddy365","volume":"28","author":"X Liu","year":"2019","unstructured":"Liu X, Hebron M, Shi W, Lonskaya I, Moussa CE. Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. Hum Mol Genet 2019, 28: 548\u2013560.","journal-title":"Hum Mol Genet"},{"key":"1613_CR67","doi-asserted-by":"publisher","first-page":"12105","DOI":"10.3390\/ijms232012105","volume":"23","author":"E Tsefou","year":"2022","unstructured":"Tsefou E, Ketteler R. Targeting deubiquitinating enzymes (DUBs) that regulate mitophagy via direct or indirect interaction with parkin. Int J Mol Sci 2022, 23: 12105.","journal-title":"Int J Mol Sci"},{"key":"1613_CR68","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.3390\/ijms23158131","volume":"23","author":"X Liu","year":"2022","unstructured":"Liu X, Balaraman K, Lynch CC, Hebron M, Shah PK, Hu S, et al. Inhibition of ubiquitin-specific protease-13 improves behavioral performance in alpha-synuclein expressing mice. Int J Mol Sci 2022, 23: 8131.","journal-title":"Int J Mol Sci"},{"key":"1613_CR69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2013.12.011","volume":"64","author":"SE Davies","year":"2014","unstructured":"Davies SE, Hallett PJ, Moens T, Smith G, Mangano E, Kim HT, et al. Enhanced ubiquitin-dependent degradation by Nedd4 protects against \u03b1-synuclein accumulation and toxicity in animal models of Parkinson\u2019s disease. Neurobiol Dis 2014, 64: 79\u201387.","journal-title":"Neurobiol Dis"},{"key":"1613_CR70","doi-asserted-by":"publisher","first-page":"9119","DOI":"10.1073\/pnas.1100028108","volume":"108","author":"M Chen","year":"2011","unstructured":"Chen M, Gutierrez GJ, Ronai ZA. Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle control. Proc Natl Acad Sci U S A 2011, 108: 9119\u20139124.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR71","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/15548627.2015.1034408","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Serricchio M, Jauregui M, Shanbhag R, Stoltz T, Di Paolo CT, et al. Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy 2015, 11: 595\u2013606.","journal-title":"Autophagy"},{"key":"1613_CR72","doi-asserted-by":"publisher","first-page":"10909","DOI":"10.1523\/JNEUROSCI.2635-09.2009","volume":"29","author":"PC Chen","year":"2009","unstructured":"Chen PC, Qin LN, Li XM, Walters BJ, Wilson JA, Mei L, et al. The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J Neurosci 2009, 29: 10909\u201310919.","journal-title":"J Neurosci"},{"key":"1613_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnmol.2015.00011","volume":"8","author":"JH Vaden","year":"2015","unstructured":"Vaden JH, Watson JA, Howard AD, Chen PC, Wilson JA, Wilson SM. Distinct effects of ubiquitin overexpression on NMJ structure and motor performance in mice expressing catalytically inactive USP14. Front Mol Neurosci 2015, 8: 11.","journal-title":"Front Mol Neurosci"},{"key":"1613_CR74","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809014","volume":"10","author":"J Chakraborty","year":"2018","unstructured":"Chakraborty J, von Stockum S, Marchesan E, Caicci F, Ferrari V, Rakovic A, et al. USP14 inhibition corrects an in vivo model of impaired mitophagy. EMBO Mol Med 2018, 10: e9014.","journal-title":"EMBO Mol Med"},{"key":"1613_CR75","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3389\/fcell.2020.00727","volume":"8","author":"C Banerjee","year":"2020","unstructured":"Banerjee C, Roy M, Mondal R, Chakraborty J. USP14 as a therapeutic target against neurodegeneration: A rat brain perspective. Front Cell Dev Biol 2020, 8: 727.","journal-title":"Front Cell Dev Biol"},{"key":"1613_CR76","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1471-4159.2005.03409.x","volume":"95","author":"C Anderson","year":"2005","unstructured":"Anderson C, Crimmins S, Wilson JA, Korbel GA, Ploegh HL, Wilson SM. Loss of Usp14 results in reduced levels of ubiquitin in Ataxia mice. J Neurochem 2005, 95: 724\u2013731.","journal-title":"J Neurochem"},{"key":"1613_CR77","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/15548627.2019.1598754","volume":"16","author":"JA Thayer","year":"2020","unstructured":"Thayer JA, Awad O, Hegdekar N, Sarkar C, Tesfay H, Burt C, et al. The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability. Autophagy 2020, 16: 140\u2013153.","journal-title":"Autophagy"},{"key":"1613_CR78","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/humu.20382","volume":"27","author":"Y Li","year":"2006","unstructured":"Li Y, Schrodi S, Rowland C, Tacey K, Catanese J, Grupe A. Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum Mutat 2006, 27: 1017\u20131023.","journal-title":"Hum Mutat"},{"key":"1613_CR79","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ana.10324","volume":"52","author":"AA Hicks","year":"2002","unstructured":"Hicks AA, P\u00e9tursson H, J\u00f3nsson T, Stef\u00e1nsson H, J\u00f3hannsd\u00f3ttir HS, Sainz J, et al. A susceptibility gene for late-onset idiopathic Parkinson\u2019s disease. Ann Neurol 2002, 52: 549\u2013555.","journal-title":"Ann Neurol"},{"key":"1613_CR80","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.3390\/molecules27123879","volume":"27","author":"H Yang","year":"2022","unstructured":"Yang H, Zeng F, Luo Y, Zheng C, Ran C, Yang J. Curcumin scaffold as a multifunctional tool for Alzheimer\u2019s disease research. Molecules 2022, 27: 3879.","journal-title":"Molecules"},{"key":"1613_CR81","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","volume":"387","author":"D Devos","year":"2022","unstructured":"Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, et al. Trial of deferiprone in Parkinson\u2019s disease. N Engl J Med 2022, 387: 2045\u20132055.","journal-title":"N Engl J Med"},{"key":"1613_CR82","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnins.2019.00381","volume":"13","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li X, Li JD. The roles of post-translational modifications on \u03b1-synuclein in the pathogenesis of Parkinson\u2019s diseases. Front Neurosci 2019, 13: 381.","journal-title":"Front Neurosci"},{"key":"1613_CR83","doi-asserted-by":"crossref","unstructured":"O\u2018Hara DM, Pawar G, Kalia SK, Kalia LV. LRRK2 and \u03b1-synuclein: Distinct or synergistic players in Parkinson\u2019s disease Front Neurosci 2020, 14: 577.","DOI":"10.3389\/fnins.2020.00577"},{"key":"1613_CR84","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/brb3.86","volume":"2","author":"Y Izawa","year":"2012","unstructured":"Izawa Y, Tateno H, Kameda H, Hirakawa K, Hato K, Yagi H, et al. Role of C-terminal negative charges and tyrosine residues in fibril formation of \u03b1-synuclein. Brain Behav 2012, 2: 595\u2013605.","journal-title":"Brain Behav"},{"key":"1613_CR85","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco G, Chen SW, Williamson PTF, Cascella R, Perni M, Jarvis JA, et al. Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers. Science 2017, 358: 1440\u20131443.","journal-title":"Science"},{"key":"1613_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014695","volume":"6","author":"LV Kalia","year":"2011","unstructured":"Kalia LV, Kalia SK, Chau H, Lozano AM, Hyman BT, McLean PJ. Ubiquitinylation of \u03b1-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS One 2011, 6: e14695.","journal-title":"PLoS One"},{"key":"1613_CR87","doi-asserted-by":"publisher","first-page":"17962","DOI":"10.1074\/jbc.M802283200","volume":"283","author":"JE Tetzlaff","year":"2008","unstructured":"Tetzlaff JE, Putcha P, Outeiro TF, Ivanov A, Berezovska O, Hyman BT, et al. CHIP targets toxic alpha-Synuclein oligomers for degradation. J Biol Chem 2008, 283: 17962\u201317968.","journal-title":"J Biol Chem"},{"key":"1613_CR88","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/genes13030513","volume":"13","author":"JA Conway","year":"2022","unstructured":"Conway JA, Kinsman G, Kramer ER. The role of NEDD4 E3 ubiquitin-protein ligases in Parkinson\u2019s disease. Genes 2022, 13: 513.","journal-title":"Genes"},{"key":"1613_CR89","doi-asserted-by":"publisher","first-page":"18137","DOI":"10.1074\/jbc.M113.529461","volume":"289","author":"N Sugeno","year":"2014","unstructured":"Sugeno N, Hasegawa T, Tanaka N, Fukuda M, Wakabayashi K, Oshima R, et al. Lys-63-linked ubiquitination by E3 ubiquitin ligase Nedd4-1 facilitates endosomal sequestration of internalized \u03b1-synuclein. J Biol Chem 2014, 289: 18137\u201318151.","journal-title":"J Biol Chem"},{"key":"1613_CR90","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.1704351114","volume":"114","author":"R Rott","year":"2017","unstructured":"Rott R, Szargel R, Shani V, Hamza H, Savyon M, Abd Elghani F, et al. SUMOylation and ubiquitination reciprocally regulate \u03b1-synuclein degradation and pathological aggregation. Proc Natl Acad Sci U S A 2017, 114: 13176\u201313181.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR91","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1073\/pnas.1109356108","volume":"108","author":"GK Tofaris","year":"2011","unstructured":"Tofaris GK, Kim HT, Hourez R, Jung JW, Kim KP, Goldberg AL. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proc Natl Acad Sci U S A 2011, 108: 17004\u201317009.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105094","volume":"148","author":"T Zheng","year":"2021","unstructured":"Zheng T, Zhang Z. Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson\u2019s disease. Neurochem Int 2021, 148: 105094.","journal-title":"Neurochem Int"},{"key":"1613_CR93","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338: 949\u2013953.","journal-title":"Science"},{"key":"1613_CR94","doi-asserted-by":"crossref","unstructured":"Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, et al. Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science 2018, 362: eaat8407.","DOI":"10.1126\/science.aat8407"},{"key":"1613_CR95","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.1060627","volume":"293","author":"H Shimura","year":"2001","unstructured":"Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson\u2019s disease. Science 2001, 293: 263\u2013269.","journal-title":"Science"},{"key":"1613_CR96","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1074\/jbc.M704809200","volume":"283","author":"R Rott","year":"2008","unstructured":"Rott R, Szargel R, Haskin J, Shani V, Shainskaya A, Manov I, et al. Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells. J Biol Chem 2008, 283: 3316\u20133328.","journal-title":"J Biol Chem"},{"key":"1613_CR97","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4161\/auto.5604","volume":"4","author":"S Engelender","year":"2008","unstructured":"Engelender S. Ubiquitination of alpha-synuclein and autophagy in Parkinson\u2019s disease. Autophagy 2008, 4: 372\u2013374.","journal-title":"Autophagy"},{"key":"1613_CR98","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.4049\/jimmunol.1403165","volume":"196","author":"E Naik","year":"2016","unstructured":"Naik E, Dixit VM. Usp9X is required for lymphocyte activation and homeostasis through its control of ZAP70 ubiquitination and PKC\u03b2 kinase activity. J Immunol 2016, 196: 3438\u20133451.","journal-title":"J Immunol"},{"key":"1613_CR99","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1145918","volume":"318","author":"N Kayagaki","year":"2007","unstructured":"Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, O\u2019Rourke KM, et al. DUBA: A deubiquitinase that regulates type I interferon production. Science 2007, 318: 1628\u20131632.","journal-title":"Science"},{"key":"1613_CR100","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/aje\/kwp288","volume":"170","author":"M Ragland","year":"2009","unstructured":"Ragland M, Hutter C, Zabetian C, Edwards K. Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson\u2019s Disease: A HuGE review and meta-analysis. Am J Epidemiol 2009, 170: 1344\u20131357.","journal-title":"Am J Epidemiol"},{"key":"1613_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0092-8674(02)01012-7","volume":"111","author":"Y Liu","year":"2002","unstructured":"Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson\u2019s disease susceptibility. Cell 2002, 111: 209\u2013218.","journal-title":"Cell"},{"key":"1613_CR102","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jocn.2010.07.142","volume":"18","author":"L Wang","year":"2011","unstructured":"Wang L, Guo JF, Nie LL, Luo L, Zuo X, Shen L, et al. Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson\u2019s disease in the Chinese population. J Clin Neurosci 2011, 18: 541\u2013544.","journal-title":"J Clin Neurosci"},{"key":"1613_CR103","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.parkreldis.2014.01.011","volume":"20","author":"S Mondello","year":"2014","unstructured":"Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A. CSF \u03b1-synuclein and UCH-L1 levels in Parkinson\u2019s disease and atypical Parkinsonian disorders. Parkinsonism Relat Disord 2014, 20: 382\u2013387.","journal-title":"Parkinsonism Relat Disord"},{"key":"1613_CR104","volume":"12","author":"H Oizumi","year":"2025","unstructured":"Oizumi H, Hasegawa T, Kawahata I, Sekimori T, Totsune T, Sugimura Y, et al. Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson\u2019s disease. Clin Park Relat Disord 2025, 12: 100313.","journal-title":"Clin Park Relat Disord"},{"key":"1613_CR105","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00401-016-1663-9","volume":"133","author":"P Wang","year":"2017","unstructured":"Wang P, Joberty G, Buist A, Vanoosthuyse A, Stancu IC, Vasconcelos B, et al. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo. Acta Neuropathol 2017, 133: 731\u2013749.","journal-title":"Acta Neuropathol"},{"key":"1613_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107315","volume":"300","author":"S Majumder","year":"2024","unstructured":"Majumder S, Srivastava M, Alam P, Saha S, Kumari R, Chand AK, et al. Hotspot site microenvironment in the deubiquitinase OTUB1 drives its stability and aggregation. J Biol Chem 2024, 300: 107315.","journal-title":"J Biol Chem"},{"key":"1613_CR107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/psyg.12900","volume":"23","author":"X Xing","year":"2023","unstructured":"Xing X, Xu F, Wang Y, Liu H. Role of the OTUB1\/IRF7\/NOX4 axis in oxidative stress injury and inflammatory responses in mice with Parkinson\u2019s disease. Psychogeriatrics 2023, 23: 32\u201344.","journal-title":"Psychogeriatrics"},{"key":"1613_CR108","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2018.01.006","volume":"112","author":"K Tanji","year":"2018","unstructured":"Tanji K, Mori F, Miki Y, Utsumi J, Sasaki H, Kakita A, et al. YOD1 attenuates neurogenic proteotoxicity through its deubiquitinating activity. Neurobiol Dis 2018, 112: 14\u201323.","journal-title":"Neurobiol Dis"},{"key":"1613_CR109","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","volume":"109","author":"G Bieri","year":"2018","unstructured":"Bieri G, Gitler AD, Brahic M. Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Neurobiol Dis 2018, 109: 219\u2013225.","journal-title":"Neurobiol Dis"},{"key":"1613_CR110","doi-asserted-by":"crossref","unstructured":"Wang L, Xu Y, Fukushige T, Saidi L, Wang X, Yu C, et al. Mono-UFMylation promotes misfolding-associated secretion of \u03b1-synuclein. Sci Adv 2024, 10: eadk2542.","DOI":"10.1126\/sciadv.adk2542"},{"key":"1613_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100854","volume":"23","author":"S Bonelli","year":"2024","unstructured":"Bonelli S, Lo Pinto M, Ye Y, M\u00fcller SA, Lichtenthaler SF, Scilabra SD. Proteomic characterization of ubiquitin carboxyl-terminal hydrolase 19 deficient cells reveals a role for USP19 in the secretion of lysosomal proteins. Mol Cell Proteomics 2024, 23: 100854.","journal-title":"Mol Cell Proteomics"},{"key":"1613_CR112","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.15252\/embj.201593489","volume":"35","author":"SN Fontaine","year":"2016","unstructured":"Fontaine SN, Zheng D, Sabbagh JJ, Martin MD, Chaput D, Darling A, et al. DnaJ\/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins. EMBO J 2016, 35: 1537\u20131549.","journal-title":"EMBO J"},{"key":"1613_CR113","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"JJ Kim","year":"2024","unstructured":"Kim JJ, Vitale D, Otani DV, Lian MM, Heilbron K, Iwaki H, et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat Genet 2024, 56: 27\u201336.","journal-title":"Nat Genet"},{"key":"1613_CR114","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12967-025-06541-z","volume":"23","author":"T Tuersong","year":"2025","unstructured":"Tuersong T, Yong YX, Chen Y, Li PS, Shataer S, Shataer M, et al. Integrating plasma circulating protein-centered multi-omics to identify potential therapeutic targets for Parkinsonian cognitive disorders. J Transl Med 2025, 23: 535.","journal-title":"J Transl Med"},{"key":"1613_CR115","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00018-023-05006-0","volume":"80","author":"S Wu","year":"2023","unstructured":"Wu S, Lin T, Xu Y. Polymorphic USP8 allele promotes Parkinson\u2019s disease by inducing the accumulation of \u03b1-synuclein through deubiquitination. Cell Mol Life Sci 2023, 80: 363.","journal-title":"Cell Mol Life Sci"},{"key":"1613_CR116","doi-asserted-by":"crossref","unstructured":"Pirooznia SK, Wang H, Panicker N, Kumar M, Neifert S, Dar MA, et al. Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson\u2019s disease. Sci Adv 2022, 8: eabh1824.","DOI":"10.1126\/sciadv.abh1824"},{"key":"1613_CR117","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jnc.15180","volume":"156","author":"T Tian","year":"2021","unstructured":"Tian T, McLean JW, Wilson JA, Wilson SM. Examination of genetic and pharmacological tools to study the proteasomal deubiquitinating enzyme ubiquitin-specific protease 14 in the nervous system. J Neurochem 2021, 156: 309\u2013323.","journal-title":"J Neurochem"},{"key":"1613_CR118","doi-asserted-by":"crossref","unstructured":"Zhang XW, Feng N, Liu YC, Guo Q, Wang JK, Bai YZ, et al. Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy. Sci Adv 2022, 8: eabo0789.","DOI":"10.1126\/sciadv.abo0789"},{"key":"1613_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101448","volume":"298","author":"J Sango","year":"2022","unstructured":"Sango J, Kakihana T, Takahashi M, Katsuragi Y, Anisimov S, Komatsu M, et al. USP10 inhibits the dopamine-induced reactive oxygen species-dependent apoptosis of neuronal cells by stimulating the antioxidant Nrf2 activity. J Biol Chem 2022, 298: 101448.","journal-title":"J Biol Chem"},{"key":"1613_CR120","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.1073\/pnas.0904880106","volume":"106","author":"J Howitt","year":"2009","unstructured":"Howitt J, Putz U, Lackovic J, Doan A, Dorstyn L, Cheng H, et al. Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons. Proc Natl Acad Sci U S A 2009, 106: 15489\u201315494.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12974-021-02334-5","volume":"18","author":"L Zhang","year":"2021","unstructured":"Zhang L, Dai L, Li D. Mitophagy in neurological disorders. J Neuroinflammation 2021, 18: 297.","journal-title":"J Neuroinflammation"},{"key":"1613_CR122","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics 2023, 13: 736\u2013766.","journal-title":"Theranostics"},{"key":"1613_CR123","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1016\/j.apsb.2024.05.012","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wang J, Yu L, Qiao G, Qin D, Yuen-Kwan Law B, et al. Mitophagy and cGAS-STING crosstalk in neuroinflammation. Acta Pharm Sin B 2024, 14: 3327\u20133361.","journal-title":"Acta Pharm Sin B"},{"key":"1613_CR124","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan BJ, Hoek S, Fon EA, Wade-Martins R. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: From familial to sporadic disease. Trends Biochem Sci 2015, 40: 200\u2013210.","journal-title":"Trends Biochem Sci"},{"key":"1613_CR125","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1083\/jcb.201801044","volume":"217","author":"JJ Lee","year":"2018","unstructured":"Lee JJ, Sanchez-Martinez A, Martinez Zarate A, Beninc\u00e1 C, Mayor U, Clague MJ, et al. Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin. J Cell Biol 2018, 217: 1613\u20131622.","journal-title":"J Cell Biol"},{"key":"1613_CR126","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.3390\/ijms21249661","volume":"21","author":"NS Swerdlow","year":"2020","unstructured":"Swerdlow NS, Wilkins HM. Mitophagy and the brain. Int J Mol Sci 2020, 21: 9661.","journal-title":"Int J Mol Sci"},{"key":"1613_CR127","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.molcel.2023.08.021","volume":"83","author":"L Uoselis","year":"2023","unstructured":"Uoselis L, Nguyen TN, Lazarou M. Mitochondrial degradation: Mitophagy and beyond. Mol Cell 2023, 83: 3404\u20133420.","journal-title":"Mol Cell"},{"key":"1613_CR128","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 2015, 85: 257\u2013273.","journal-title":"Neuron"},{"key":"1613_CR129","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","volume":"33","author":"A Eiyama","year":"2015","unstructured":"Eiyama A, Okamoto K. PINK1\/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol 2015, 33: 95\u2013101.","journal-title":"Curr Opin Cell Biol"},{"key":"1613_CR130","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-018-0224-x","volume":"559","author":"C Gladkova","year":"2018","unstructured":"Gladkova C, Maslen SL, Skehel JM, Komander D. Mechanism of parkin activation by PINK1. Nature 2018, 559: 410\u2013414.","journal-title":"Nature"},{"key":"1613_CR131","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-020-00229-8","volume":"10","author":"I Kamienieva","year":"2021","unstructured":"Kamienieva I, Duszy\u0144ski J, Szczepanowska J. Multitasking guardian of mitochondrial quality: Parkin function and Parkinson\u2019s disease. Transl Neurodegener 2021, 10: 5.","journal-title":"Transl Neurodegener"},{"key":"1613_CR132","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/med.21938","volume":"43","author":"X Sun","year":"2023","unstructured":"Sun X, Ye G, Mai Y, Shu Y, Wang L, Zhang J. Parkin exerts the tumor-suppressive effect through targeting mitochondria. Med Res Rev 2023, 43: 855\u2013871.","journal-title":"Med Res Rev"},{"key":"1613_CR133","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/cancers15041112","volume":"15","author":"SC Jee","year":"2023","unstructured":"Jee SC, Cheong H. Autophagy\/mitophagy regulated by ubiquitination: A promising pathway in cancer therapeutics. Cancers 2023, 15: 1112.","journal-title":"Cancers"},{"key":"1613_CR134","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra DP, Youle RJ. The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol 2024, 26: 1639\u20131651.","journal-title":"Nat Cell Biol"},{"key":"1613_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z, et al. PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 2023, 84: 101817.","journal-title":"Ageing Res Rev"},{"key":"1613_CR136","doi-asserted-by":"publisher","first-page":"6637","DOI":"10.1073\/pnas.1506593112","volume":"112","author":"A Ordureau","year":"2015","unstructured":"Ordureau A, Heo JM, Duda DM, Paulo JA, Olszewski JL, Yanishevski D, et al. Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc Natl Acad Sci U S A 2015, 112: 6637\u20136642.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR137","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tibs.2019.08.002","volume":"45","author":"L Wang","year":"2020","unstructured":"Wang L, Qi H, Tang Y, Shen HM. Post-translational modifications of key machinery in the control of mitophagy. Trends Biochem Sci 2020, 45: 58\u201375.","journal-title":"Trends Biochem Sci"},{"key":"1613_CR138","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41418-019-0404-8","volume":"27","author":"F Strappazzon","year":"2020","unstructured":"Strappazzon F, Di Rita A, Peschiaroli A, Leoncini PP, Locatelli F, Melino G, et al. HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy. Cell Death Differ 2020, 27: 1155\u20131168.","journal-title":"Cell Death Differ"},{"key":"1613_CR139","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/cdd.2014.139","volume":"22","author":"F Strappazzon","year":"2015","unstructured":"Strappazzon F, Nazio F, Corrado M, Cianfanelli V, Romagnoli A, Fimia GM, et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62\/SQSTM1. Cell Death Differ 2015, 22: 419\u2013432.","journal-title":"Cell Death Differ"},{"key":"1613_CR140","doi-asserted-by":"crossref","unstructured":"Di Rita A, Peschiaroli A, D Acunzo P, Strobbe D, Hu Z, Gruber J, et al. HUWE1 E3 ligase promotes PINK1\/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKK\u03b1. Nat Commun 2018, 9: 3755.","DOI":"10.1038\/s41467-018-05722-3"},{"key":"1613_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13731","volume":"21","author":"F Abd Elghani","year":"2022","unstructured":"Abd Elghani F, Safory H, Hamza H, Savyon M, Farhoud M, Toren-Hershoviz M, et al. SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson\u2019s disease. Aging Cell 2022, 21: e13731.","journal-title":"Aging Cell"},{"key":"1613_CR142","doi-asserted-by":"publisher","unstructured":"Wang W, Li E, Zou J, Qu C, Ayala J, Wen Y, et al. The ubiquitin ligase RBX2\/SAG regulates mitochondrial ubiquitination and mitophagy. bioRxiv 2024. https:\/\/doi.org\/10.1101\/2024.02.24.581168.","DOI":"10.1101\/2024.02.24.581168"},{"key":"1613_CR143","doi-asserted-by":"publisher","unstructured":"Campos Y, Rodriguez-Enriquez R, Palacios G, Van de Vlekkert D, Qiu X, Weesner J, et al. Mitochondrial proteostasis mediated by CRL5 (Ozz) and Alix maintains skeletal muscle function. bioRxiv 2023. https:\/\/doi.org\/10.1101\/2023.07.11.548601.","DOI":"10.1101\/2023.07.11.548601"},{"key":"1613_CR144","first-page":"3280","volume":"127","author":"S Geisler","year":"2014","unstructured":"Geisler S, Vollmer S, Golombek S, Kahle PJ. The ubiquitin-conjugating enzymes UBE2N, UBE2L3 and UBE2D2\/3 are essential for Parkin-dependent mitophagy. J Cell Sci 2014, 127: 3280\u20133293.","journal-title":"J Cell Sci"},{"key":"1613_CR145","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1074\/jbc.M112.399345","volume":"288","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Massen S, Terenzio M, Lang V, Chen-Lindner S, Eils R, et al. Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J Biol Chem 2013, 288: 1099\u20131113.","journal-title":"J Biol Chem"},{"key":"1613_CR146","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41598-017-01258-6","volume":"7","author":"VV Rogov","year":"2017","unstructured":"Rogov VV, Suzuki H, Marinkovi\u0107 M, Lang V, Kato R, Kawasaki M, et al. Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins. Sci Rep 2017, 7: 1131.","journal-title":"Sci Rep"},{"key":"1613_CR147","doi-asserted-by":"publisher","first-page":"19094","DOI":"10.1074\/jbc.M111.322933","volume":"287","author":"RA Hanna","year":"2012","unstructured":"Hanna RA, Quinsay MN, Orogo AM, Giang K, Rikka S, Gustafsson \u00c5B. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 2012, 287: 19094\u201319104.","journal-title":"J Biol Chem"},{"key":"1613_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111879","volume":"134","author":"X Wu","year":"2025","unstructured":"Wu X, Wen Y, Yuan Y, Bai T, Yang N, Xu L, et al. The AKT-USP15 axis modulates autophagy in MPP(+)-induced Parkinson\u2019s disease model of SN4741 cells. Cell Signal 2025, 134: 111879.","journal-title":"Cell Signal"},{"key":"1613_CR149","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1080\/15548627.2021.2022360","volume":"18","author":"X Qin","year":"2022","unstructured":"Qin X, Wang R, Xu H, Tu L, Chen H, Li H, et al. Identification of an autoinhibitory, mitophagy-inducing peptide derived from the transmembrane domain of USP30. Autophagy 2022, 18: 2178\u20132197.","journal-title":"Autophagy"},{"key":"1613_CR150","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1038\/s41467-023-42876-1","volume":"14","author":"TZ Fang","year":"2023","unstructured":"Fang TZ, Sun Y, Pearce AC, Eleuteri S, Kemp M, Luckhurst CA, et al. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson\u2019s disease mouse model. Nat Commun 2023, 14: 7295.","journal-title":"Nat Commun"},{"key":"1613_CR151","doi-asserted-by":"publisher","first-page":"105606","DOI":"10.18632\/oncotarget.22348","volume":"8","author":"L Shi","year":"2017","unstructured":"Shi L, Huang C, Luo Q, Xia Y, Liu H, Li L, et al. Pilot study: Molecular risk factors for diagnosing sporadic Parkinson\u2019s disease based on gene expression in blood in MPTP-induced Rhesus monkeys. Oncotarget 2017, 8: 105606\u2013105614.","journal-title":"Oncotarget"},{"key":"1613_CR152","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41419-024-06439-6","volume":"15","author":"J Okarmus","year":"2024","unstructured":"Okarmus J, Agergaard JB, Stummann TC, Haukedal H, Ambj\u00f8rn M, Freude KK, et al. USP30 inhibition induces mitophagy and reduces oxidative stress in parkin-deficient human neurons. Cell Death Dis 2024, 15: 52.","journal-title":"Cell Death Dis"},{"key":"1613_CR153","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cdd.2009.43","volume":"17","author":"SC Sun","year":"2010","unstructured":"Sun SC. CYLD: A tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ 2010, 17: 25\u201334.","journal-title":"Cell Death Differ"},{"key":"1613_CR154","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1021\/bi400780v","volume":"52","author":"JJ Bai","year":"2013","unstructured":"Bai JJ, Safadi SS, Mercier P, Barber KR, Shaw GS. Ataxin-3 is a multivalent ligand for the parkin Ubl domain. Biochemistry 2013, 52: 7369\u20137376.","journal-title":"Biochemistry"},{"key":"1613_CR155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029362","volume":"6","author":"YH Zhang","year":"2011","unstructured":"Zhang YH, Zhou CJ, Zhou ZR, Song AX, Hu HY. Domain analysis reveals that a deubiquitinating enzyme USP13 performs non-activating catalysis for Lys63-linked polyubiquitin. PLoS One 2011, 6: e29362.","journal-title":"PLoS One"},{"key":"1613_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.977122","volume":"9","author":"Q Wang","year":"2022","unstructured":"Wang Q, Sun Z, Xia W, Sun L, Du Y, Zhang Y, et al. Role of USP13 in physiology and diseases. Front Mol Biosci 2022, 9: 977122.","journal-title":"Front Mol Biosci"},{"key":"1613_CR157","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1128\/MCB.01566-06","volume":"27","author":"S Niendorf","year":"2007","unstructured":"Niendorf S, Oksche A, Kisser A, L\u00f6hler J, Prinz M, Schorle H, et al. Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol Cell Biol 2007, 27: 5029\u20135039.","journal-title":"Mol Cell Biol"},{"key":"1613_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001238","volume":"10","author":"R Xia","year":"2012","unstructured":"Xia R, Jia H, Fan J, Liu Y, Jia J. USP8 promotes smoothened signaling by preventing its ubiquitination and changing its subcellular localization. PLoS Biol 2012, 10: e1001238.","journal-title":"PLoS Biol"},{"key":"1613_CR159","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1186\/s12967-024-05565-1","volume":"22","author":"Y Wu","year":"2024","unstructured":"Wu Y, Chen Y, Tian X, Shao G, Lin Q, Sun A. Ubiquitination regulates autophagy in cancer: Simple modifications, promising targets. J Transl Med 2024, 22: 985.","journal-title":"J Transl Med"},{"key":"1613_CR160","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2018.07.005","volume":"122","author":"CS Evans","year":"2019","unstructured":"Evans CS, Holzbaur ELF. Autophagy and mitophagy in ALS. Neurobiol Dis 2019, 122: 35\u201340.","journal-title":"Neurobiol Dis"},{"key":"1613_CR161","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.14336\/AD.2023.0713","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Li X, Zhang Q, Fu C, Jiang W, Xue J, et al. Autophagy in disease onset and progression. Aging Dis 2024, 15: 1646\u20131671.","journal-title":"Aging Dis"},{"key":"1613_CR162","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/cdd.2012.72","volume":"20","author":"S Shaid","year":"2013","unstructured":"Shaid S, Brandts CH, Serve H, Dikic I. Ubiquitination and selective autophagy. Cell Death Differ 2013, 20: 21\u201330.","journal-title":"Cell Death Differ"},{"key":"1613_CR163","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev-biochem-061516-044820","volume":"86","author":"JH Hurley","year":"2017","unstructured":"Hurley JH, Young LN. Mechanisms of autophagy initiation. Annu Rev Biochem 2017, 86: 225\u2013244.","journal-title":"Annu Rev Biochem"},{"key":"1613_CR164","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/dna.2014.2765","volume":"34","author":"T Martins-Marques","year":"2015","unstructured":"Martins-Marques T, Ribeiro-Rodrigues T, Pereira P, Codogno P, Girao H. Autophagy and ubiquitination in cardiovascular diseases. DNA Cell Biol 2015, 34: 243\u2013251.","journal-title":"DNA Cell Biol"},{"key":"1613_CR165","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12929-019-0569-y","volume":"26","author":"RH Chen","year":"2019","unstructured":"Chen RH, Chen YH, Huang TY. Ubiquitin-mediated regulation of autophagy. J Biomed Sci 2019, 26: 80.","journal-title":"J Biomed Sci"},{"key":"1613_CR166","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/emboj.2010.74","volume":"29","author":"H Weidberg","year":"2010","unstructured":"Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z. LC3 and GATE-16\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J 2010, 29: 1792\u20131802.","journal-title":"EMBO J"},{"key":"1613_CR167","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1080\/15548627.2021.1953820","volume":"17","author":"J Yang","year":"2021","unstructured":"Yang J, Chen X, Xu H. SQSTM1\/p62 droplet-mediated autophagosome formation: Insights into Huntington disease. Autophagy 2021, 17: 3256\u20133259.","journal-title":"Autophagy"},{"key":"1613_CR168","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.molcel.2023.09.004","volume":"83","author":"X Huang","year":"2023","unstructured":"Huang X, Yao J, Liu L, Chen J, Mei L, Huangfu J, et al. S-acylation of p62 promotes p62 droplet recruitment into autophagosomes in mammalian autophagy. Mol Cell 2023, 83: 3485-3501.e11.","journal-title":"Mol Cell"},{"key":"1613_CR169","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.molcel.2009.01.020","volume":"33","author":"V Kirkin","year":"2009","unstructured":"Kirkin V, Lamark T, Sou YS, Bj\u00f8rk\u00f8y G, Nunn JL, Bruun JA, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 2009, 33: 505\u2013516.","journal-title":"Mol Cell"},{"key":"1613_CR170","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1080\/15548627.2018.1471311","volume":"14","author":"F Ikeda","year":"2018","unstructured":"Ikeda F. The anti-apoptotic ubiquitin conjugating enzyme BIRC6\/BRUCE regulates autophagosome-lysosome fusion. Autophagy 2018, 14: 1283\u20131284.","journal-title":"Autophagy"},{"key":"1613_CR171","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41467-018-02823-x","volume":"9","author":"P Ebner","year":"2018","unstructured":"Ebner P, Poetsch I, Deszcz L, Hoffmann T, Zuber J, Ikeda F. The IAP family member BRUCE regulates autophagosome-lysosome fusion. Nat Commun 2018, 9: 599.","journal-title":"Nat Commun"},{"key":"1613_CR172","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1073\/pnas.1901039116","volume":"116","author":"TX Jiang","year":"2019","unstructured":"Jiang TX, Zou JB, Zhu QQ, Liu CH, Wang GF, Du TT, et al. SIP\/CacyBP promotes autophagy by regulating levels of BRUCE\/Apollon, which stimulates LC3-I degradation. Proc Natl Acad Sci U S A 2019, 116: 13404\u201313413.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1613_CR173","doi-asserted-by":"publisher","first-page":"1410139","DOI":"10.3389\/fnins.2024.1410139","volume":"18","author":"M Favaro","year":"2024","unstructured":"Favaro M, Mauri S, Bernardo G, Zordan MA, Mazzotta GM, Ziviani E. Usp14 down-regulation corrects sleep and circadian dysfunction of a Drosophila model of Parkinson\u2019s disease. Front Neurosci 2024, 18: 1410139.","journal-title":"Front Neurosci"},{"key":"1613_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084042","volume":"8","author":"AG Marshall","year":"2013","unstructured":"Marshall AG, Watson JA, Hallengren JJ, Walters BJ, Dobrunz LE, Francillon L, et al. Genetic background alters the severity and onset of neuromuscular disease caused by the loss of ubiquitin-specific protease 14 (usp14). PLoS One 2013, 8: e84042.","journal-title":"PLoS One"},{"key":"1613_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107484","volume":"210","author":"G Bernardo","year":"2024","unstructured":"Bernardo G, Prado MA, Dashtmian AR, Favaro M, Mauri S, Borsetto A, et al. USP14 inhibition enhances Parkin-independent mitophagy in iNeurons. Pharmacol Res 2024, 210: 107484.","journal-title":"Pharmacol Res"},{"key":"1613_CR176","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/jnc.12626","volume":"128","author":"K Wang","year":"2014","unstructured":"Wang K, Liu S, Wang J, Wu Y, Cai F, Song W. Transcriptional regulation of human USP24 gene expression by NF-kappa B. J Neurochem 2014, 128: 818\u2013828.","journal-title":"J Neurochem"},{"key":"1613_CR177","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1086\/432588","volume":"77","author":"SA Oliveira","year":"2005","unstructured":"Oliveira SA, Li YJ, Noureddine MA, Zuchner S, Qin X, Pericak-Vance MA, et al. Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am J Hum Genet 2005, 77: 252\u2013264.","journal-title":"Am J Hum Genet"},{"key":"1613_CR178","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.parkreldis.2013.10.001","volume":"20","author":"JY Wan","year":"2014","unstructured":"Wan JY, Edwards KL, Hutter CM, Mata IF, Samii A, Roberts JW, et al. Association mapping of the PARK10 region for Parkinson\u2019s disease susceptibility genes. Parkinsonism Relat Disord 2014, 20: 93\u201398.","journal-title":"Parkinsonism Relat Disord"},{"key":"1613_CR179","doi-asserted-by":"crossref","unstructured":"Celemuge, Sun H, Zhang J, Yang Y, Mao J, Cheliger. USP10 in neurological disorders: Mechanistic insights and emerging therapeutic strategies. Ann N Y Acad Sci 2026, 1556: e70144.","DOI":"10.1111\/nyas.70144"},{"key":"1613_CR180","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/ph15081014","volume":"15","author":"QX Chen","year":"2022","unstructured":"Chen QX, Zhou L, Long T, Qin DL, Wang YL, Ye Y, et al. Galangin exhibits neuroprotective effects in 6-OHDA-induced models of Parkinson\u2019s disease via the Nrf2\/Keap1 pathway. Pharmaceuticals 2022, 15: 1014.","journal-title":"Pharmaceuticals"},{"key":"1613_CR181","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12974-025-03455-x","volume":"22","author":"H Jia","year":"2025","unstructured":"Jia H, Liu M, Jiang H, Qiao Z, Ren K, Du X, et al. Repurposing of epalrestat for neuroprotection in Parkinson\u2019s disease via activation of the KEAP1\/Nrf2 pathway. J Neuroinflammation 2025, 22: 125.","journal-title":"J Neuroinflammation"},{"key":"1613_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103116","volume":"71","author":"X Sun","year":"2024","unstructured":"Sun X, Guo C, Huang C, Lv N, Chen H, Huang H, et al. GSTP alleviates acute lung injury by S-glutathionylation of KEAP1 and subsequent activation of NRF2 pathway. Redox Biol 2024, 71: 103116.","journal-title":"Redox Biol"},{"key":"1613_CR183","doi-asserted-by":"publisher","first-page":"2309331","DOI":"10.1002\/advs.202309331","volume":"11","author":"W Qi","year":"2024","unstructured":"Qi W, Liu C, Shi L, Li H, Hou X, Du H, et al. CD169+ macrophages mediate the immune response of allergic rhinitis through the Keap1\/Nrf2\/HO-1 axis. Adv Sci 2024, 11: 2309331.","journal-title":"Adv Sci"},{"key":"1613_CR184","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1007\/s12035-020-02049-3","volume":"57","author":"Y Sun","year":"2020","unstructured":"Sun Y, He L, Wang T, Hua W, Qin H, Wang J, et al. Activation of p62-Keap1-Nrf2 pathway protects 6-hydroxydopamine-induced ferroptosis in dopaminergic cells. Mol Neurobiol 2020, 57: 4628\u20134641.","journal-title":"Mol Neurobiol"},{"key":"1613_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188903","volume":"1878","author":"G Saha","year":"2023","unstructured":"Saha G, Roy S, Basu M, Ghosh MK. USP7 - a crucial regulator of cancer hallmarks. Biochim Biophys Acta Rev Cancer 2023, 1878: 188903.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1613_CR186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290371","volume":"18","author":"SH Lee","year":"2023","unstructured":"Lee SH, Chung KC. USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. PLoS One 2023, 18: e0290371.","journal-title":"PLoS One"},{"key":"1613_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102077","volume":"91","author":"XS Ding","year":"2023","unstructured":"Ding XS, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, et al. Ferroptosis in Parkinson\u2019s disease: Molecular mechanisms and therapeutic potential. Ageing Res Rev 2023, 91: 102077.","journal-title":"Ageing Res Rev"},{"key":"1613_CR188","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.7150\/thno.98172","volume":"14","author":"Y Yong","year":"2024","unstructured":"Yong Y, Yan L, Wei J, Feng C, Yu L, Wu J, et al. A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer\u2019s disease by activating GPX4. Theranostics 2024, 14: 6161\u20136184.","journal-title":"Theranostics"},{"key":"1613_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155463","volume":"127","author":"YY Yong","year":"2024","unstructured":"Yong YY, Yan L, Wang BD, Fan DS, Guo MS, Yu L, et al. Penthorum chinense Pursh inhibits ferroptosis in cellular and Caenorhabditis elegans models of Alzheimer\u2019s disease. Phytomedicine 2024, 127: 155463.","journal-title":"Phytomedicine"},{"key":"1613_CR190","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.1016\/S1353-8020(09)70816-8","volume":"15","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC. Iron transport in Parkinson\u2019s disease. Parkinsonism Relat Disord 2009, 15: S209\u2013S211.","journal-title":"Parkinsonism Relat Disord"},{"key":"1613_CR191","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1021\/acs.biochem.0c00504","volume":"59","author":"AA Gholkar","year":"2020","unstructured":"Gholkar AA, Schmollinger S, Velasquez EF, Lo YC, Cohn W, Capri J, et al. Regulation of iron homeostasis through parkin-mediated lactoferrin ubiquitylation. Biochemistry 2020, 59: 2916\u20132921.","journal-title":"Biochemistry"},{"key":"1613_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104657","volume":"134","author":"YZ Ci","year":"2020","unstructured":"Ci YZ, Li H, You LH, Jin Y, Zhou R, Gao G, et al. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson\u2019s disease. Neurochem Int 2020, 134: 104657.","journal-title":"Neurochem Int"},{"key":"1613_CR193","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/84859","volume":"27","author":"T LaVaute","year":"2001","unstructured":"LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001, 27: 209\u2013214.","journal-title":"Nat Genet"},{"key":"1613_CR194","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.1176326","volume":"326","author":"AA Salahudeen","year":"2009","unstructured":"Salahudeen AA, Thompson JW, Ruiz JC, Ma HW, Kinch LN, Li Q, et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 2009, 326: 722\u2013726.","journal-title":"Science"},{"key":"1613_CR195","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","volume":"67","author":"S Wang","year":"2019","unstructured":"Wang S, Yuan YH, Chen NH, Wang HB. The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease. Int Immunopharmacol 2019, 67: 458\u2013464.","journal-title":"Int Immunopharmacol"},{"key":"1613_CR196","doi-asserted-by":"publisher","first-page":"8780","DOI":"10.3390\/ijms22168780","volume":"22","author":"M Akther","year":"2021","unstructured":"Akther M, Haque ME, Park J, Kang TB, Lee KH. NLRP3 ubiquitination-a new approach to target NLRP3 inflammasome activation. Int J Mol Sci 2021, 22: 8780.","journal-title":"Int J Mol Sci"},{"key":"1613_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1404","volume":"11","author":"S Lara-Reyna","year":"2022","unstructured":"Lara-Reyna S, Caseley EA, Topping J, Rodrigues F, Jimenez Macias J, Lawler SE, et al. Inflammasome activation: From molecular mechanisms to autoinflammation. Clin Transl Immunology 2022, 11: e1404.","journal-title":"Clin Transl Immunology"},{"key":"1613_CR198","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350382","volume":"53","author":"Y Qin","year":"2023","unstructured":"Qin Y, Zhao W. Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation. Eur J Immunol 2023, 53: e2350382.","journal-title":"Eur J Immunol"},{"key":"1613_CR199","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.1172\/JCI138234","volume":"130","author":"Y Guo","year":"2020","unstructured":"Guo Y, Li L, Xu T, Guo X, Wang C, Li Y, et al. HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection. J Clin Invest 2020, 130: 6301\u20136316.","journal-title":"J Clin Invest"},{"key":"1613_CR200","doi-asserted-by":"publisher","first-page":"708","DOI":"10.17305\/bb.2023.9997","volume":"24","author":"S Tang","year":"2024","unstructured":"Tang S, Geng Y, Wang Y, Lin Q, Yu Y, Li H. The roles of ubiquitination and deubiquitination of NLRP3 inflammasome in inflammation-related diseases: A review. Biomol Biomed 2024, 24: 708\u2013721.","journal-title":"Biomol Biomed"},{"key":"1613_CR201","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.4049\/jimmunol.2001178","volume":"206","author":"J Ni","year":"2021","unstructured":"Ni J, Guan C, Liu H, Huang X, Yue J, Xiang H, et al. Ubc13 promotes K63-linked polyubiquitination of NLRP3 to activate inflammasome. J Immunol 2021, 206: 2376\u20132385.","journal-title":"J Immunol"},{"key":"1613_CR202","doi-asserted-by":"crossref","unstructured":"Sadier NS, Ali Hazimeh I, Khazaal W, Al Khayat Al Sabouri A, Almutary AG, Alnuqaydan AM, et al. Exploring the therapeutic potential of NLRP3 inhibitors in Parkinson\u2019s Disease: A systematic review of in-vivo studies. Inflammopharmacology 2025, 33: 2657\u20132677.","DOI":"10.1007\/s10787-025-01733-x"},{"key":"1613_CR203","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13834","volume":"22","author":"YQ Yan","year":"2023","unstructured":"Yan YQ, Zheng R, Liu Y, Ruan Y, Lin ZH, Xue NJ, et al. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson\u2019s disease. Aging Cell 2023, 22: e13834.","journal-title":"Aging Cell"},{"key":"1613_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112967","volume":"410","author":"X Li","year":"2022","unstructured":"Li X, Wang T, Tao Y, Wang X, Li L, Liu J. MF-094, a potent and selective USP30 inhibitor, accelerates diabetic wound healing by inhibiting the NLRP3 inflammasome. Exp Cell Res 2022, 410: 112967.","journal-title":"Exp Cell Res"},{"key":"1613_CR205","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201744766","volume":"19","author":"P Palaz\u00f3n-Riquelme","year":"2018","unstructured":"Palaz\u00f3n-Riquelme P, Worboys JD, Green J, Valera A, Mart\u00edn-S\u00e1nchez F, Pellegrini C, et al. USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep 2018, 19: e44766.","journal-title":"EMBO Rep"},{"key":"1613_CR206","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1038\/s41467-020-19939-8","volume":"11","author":"H Song","year":"2020","unstructured":"Song H, Zhao C, Yu Z, Li Q, Yan R, Qin Y, et al. UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression. Nat Commun 2020, 11: 6042.","journal-title":"Nat Commun"},{"key":"1613_CR207","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1021\/acs.jproteome.4c00618","volume":"24","author":"DP O\u2019Brien","year":"2025","unstructured":"O\u2019Brien DP, Jones HBL, Shi Y, Guenther F, Vendrell I, Viner R, et al. Structural dynamics of the ubiquitin specific protease USP30 in complex with a cyanopyrrolidine-containing covalent inhibitor. J Proteome Res 2025, 24: 479\u2013490.","journal-title":"J Proteome Res"},{"key":"1613_CR208","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/cr.2014.20","volume":"24","author":"W Yue","year":"2014","unstructured":"Yue W, Chen Z, Liu H, Yan C, Chen M, Feng D, et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res 2014, 24: 482\u2013496.","journal-title":"Cell Res"},{"key":"1613_CR209","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000768","volume":"3","author":"EV Rusilowicz-Jones","year":"2020","unstructured":"Rusilowicz-Jones EV, Jardine J, Kallinos A, Pinto-Fernandez A, Guenther F, Giurrandino M, et al. USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation. Life Sci Alliance 2020, 3: e202000768.","journal-title":"Life Sci Alliance"},{"key":"1613_CR210","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2018.02.140","volume":"497","author":"C Yan","year":"2018","unstructured":"Yan C, Huo H, Yang C, Zhang T, Chu Y, Liu Y. Ubiquitin C-Terminal Hydrolase L1 regulates autophagy by inhibiting autophagosome formation through its deubiquitinating enzyme activity. Biochem Biophys Res Commun 2018, 497: 726\u2013733.","journal-title":"Biochem Biophys Res Commun"},{"key":"1613_CR211","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034713","volume":"7","author":"AE Cartier","year":"2012","unstructured":"Cartier AE, Ubhi K, Spencer B, Vazquez-Roque RA, Kosberg KA, Fourgeaud L, et al. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy. PLoS One 2012, 7: e34713.","journal-title":"PLoS One"},{"key":"1613_CR212","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature09299","volume":"467","author":"BH Lee","year":"2010","unstructured":"Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, Chen PC, et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 2010, 467: 179\u2013184.","journal-title":"Nature"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01613-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01613-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:02:57Z","timestamp":1788512577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-026-01613-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":212,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1007\/s12264-026-01613-6","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}